Recruiting OBSERVATIONAL NCT05804643

Novel MRI Techniques on Evaluation of Lymphedema

Development and Optimization of Novel MRI Techniques on Evaluation of Therapeutic Effects for Lymphedema Secondary to Breast Cancer Treatment: An Integrated Study of Pre-clinical Animal Models and Clinical Follow-up

Sponsor: National Health Research Institutes, Taiwan

Conditions Lymphedema of Upper Limb

Interventions Diffusion magnetic resonance imaging

Updated 3 times since 2023 Last updated: Apr 16, 2023 Started: Apr 10, 2023 Primary completion: Dec 31, 2024 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Lymphedema of Upper Limb and is currently actively recruiting participants. National Health Research Institutes, Taiwan leads this study, which shows 3 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
May 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Apr 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Health Research Institutes, Taiwan
National Taiwan University Hospital

Data source: National Taiwan University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan